Stay updated on Pembrolizumab for EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for EGFR+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays a revision label 'Revision: v3.3.2' replacing the previous 'Revision: v3.3.1'.
    Difference
    0.1%
    Check dated 2025-12-01T15:41:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Publications section now clarifies PubMed as the source of auto-filled articles and that they may not pertain to the study. The page revision tag has been updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:10:10.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A site-wide funding/operating status notice was removed. This does not modify the study details, eligibility criteria, or results displayed on the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:08:15.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new screenshots; the page content and structure appear the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:44:55.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Update adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-05T06:41:28.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T02:54:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.